Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)
Diabetes Care - United States
doi 10.2337/dc13-2759
Full Text
Open PDFAbstract
Available in full text
Date
May 19, 2014
Authors
Publisher
American Diabetes Association